S
ingle-stranded DNAwith CpG (unmethylated deoxycytidylyldeoxyguanosine) dinucleotide motifs, characteristic of bacteria and virus genomes, activates the immune response against invading pathogens (1) . The frequency of the cytidineguanosine (CG) dinucleotide is strongly underrepresented in the human genome, and ∼80% of the cytidine in the CG dinucleotide is methylated, which establishes the recognition of DNA-comprising CpG motifs as the structural pattern for the innate immune response. Synthetic ssDNA fragments, oligodeoxyribonucleotides (ODNs) containing stimulatory CpG motifs, also initiate immune signaling in a TLR9-MyD88-dependent fashion, leading to the activation of transcription factors NF-kB and IRF7 and, consequently, the secretion of cytokines and chemokines by B cells, plasmacytoid dendritic cells (pDCs), NK cells, and macrophages that express TLR9 (2, 3) . Membrane receptors-mannose receptor 1 (4), Iglike receptor KIR3DL2 (5), multilectin receptor DEC-205 (6) , and scavenger receptor CXCL16 (7)-enhance internalization and define the route of endocytosis of ODNs.
Several types of CpG ODNs, each with a distinct sequence, secondary structure, and specificity for TLR9 activation (8) , are potent activators of Th1-type cytokines and so are used as adjuvants (9, 10) . The B-class CpG ODNs (alias K-type) with the CG motif and a phosphorothioate (PTO) backbone are strong stimulators of B cell proliferation as well as the secretion of IL-6, IL-10, and IL-12 through NF-kB signaling (1, 11) . A-class ODNs (alias D-type), which are poor stimulators of B cells, contain a palindromic sequence at the center of the ODN and poly-G motif, which can form quadruplexes at each end. These ODNs activate NK cells, and in pDCs, A-class ODNs induce secretion of type I IFNs (IFN-a/b), TNF-a, IL-12, and IFN-g-IP10 (12) (13) (14) . C-class ODNs are chimeras of A-and B-class ODNs with one or two CGT motifs at the 59 end and a CG-rich palindromic sequence at the 39 end of the ODN. This class of CpG ODNs possesses the immune-stimulatory properties of the A-and B-class ODNs and induces proliferation of B cells and the production of low amounts of IFN-a from pDCs (15, 16) . A-, C-, and P-class (17, 18) CpG ODNs form intra-and intermolecular duplexes. These multi-ODN structures are suggested to take a different route of endocytosis and, therefore, induce the synthesis of type I IFNs (17, 19) . In addition to unmethylated CpG motifs within the ODN, other factors determine the immune response of TLR9-expressing cells. The position, number, and accessibility of CpG motifs, the nucleotides adjacent to the CG dinucleotide, and the secondary structures of the ODNs influence agonist potency for TLR9 activation (15, (20) (21) (22) (23) . Moreover, CpG ODNs show sequence-species specificity for the activation of TLR9. GACGTT has been proposed as the optimal TLR9 recognition hexamer for mice (1, 24) , whereas GTCGTT is optimal for humans (12) and other vertebrate species (25) .
The naturally occurring agonist of TLR9 is ssDNA with a phosphodiester (PD) backbone. To prevent degradation of ODNs by deoxyribonucleases, synthetic ODNs may consist of a partial or complete PTO backbone. Some important differences are noted in terms of TLR9 activation between ODNs based on a PD backbone and those based on a PTO backbone. A base-free PD-deoxyribose homopolymer is a very weak TLR9 agonist (26) , whereas the basefree PTO homopolymer does not activate TLR9 but instead competitively inhibits TLR9 activation in the presence of B-class ODN, which is not the case for the PD homopolymer (26) .
In this study, we aimed to define the sequence and functional features of ODNs that govern TLR9 activation and the minimal sequence requirements for strong ODN stimulation of the immune response in human B cells and human TLR9-expressing HEK293 cells. We systematically analyzed which sequence motifs in B-class ODN2006 PD and C-class ODN2395 PD are necessary to effectively activate TLR9. The impact of the nucleotide context and the distance between the CpG motifs, as well as the effect of ODN duplex formation on TLR9 activity, were determined. Finally, we established the minimal ODNs defined by the sequence TCG[T] 6-10 CG[T] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] and a total length of .21 nt. These minimal ODNs induce production of TNF-a in human PBMCs. 
Materials and Methods

Cell cultures and reagents
Activity assay
Human B lymphocyte Ramos-Blue cells were seeded at a density of 2 3 10 5 cells per well onto Costar 96-well plates (Corning). The cells were immediately stimulated with ODNs (5 mM final concentration, if not stated otherwise). After 20 h, the supernatants were collected and heated to 56˚C for 1 h, and then NF-kB/AP-1 activation linked to secreted alkaline phosphatase was determined using a QUANTI-Blue reagent according to the manufacturer's instructions (InvivoGen). Normalized alkaline phosphatase was calculated relative to the ODN2006 output. Error bars represent the SD obtained from three experimental replicates. The data are representative of at least two independent experiments. HEK293 cells were harvested from actively growing culture and plated onto Costar Clear White 96-well plates (Corning) at 3 3 10 4 cells per well. After 24 h at 70% confluency, they were transfected with a mixture of jetPEI reagent and plasmid DNA according to the manufacturer's instructions (PolyPlus Transfection). For the TLR9-expressing cells, we used 50 ng pUNO-hTLR9-HA plasmid (InvivoGen), 150 ng ELAM1-luc reporter plasmid expressing firefly luciferase under control of the NF-kB promoter, and 5 ng phRL-TK (Promega) transfection control plasmid expressing Renilla luciferase. At 24 h after transfection, the culture medium was replaced with fresh DMEM with 10% FBS, and the cells were treated with ODNs (5 mM final concentration). After 18-20 h, the cells were lysed in passive lysis buffer (Promega), and the expression of the luciferase reporter genes was analyzed using Dual-Glo Luciferase Assay System reagents (Promega) and the Orion luminometer plate reader (Berthold Detection Systems). Relative luciferase activity was calculated by normalizing each sample's firefly luciferase activity with the constitutive Renilla luciferase activity determined within the same sample. Normalized relative luciferase activity was calculated relative to the ODN2006 output. Error bars represent the SD obtained from three experimental replicates. The data are representative of at least three independent experiments.
Immunoblotting and confocal microscopy HEK293T cells were transiently transfected with plasmids expressing hTLR9 HA (1470 ng DNA per well) and mCerulean (10 ng DNA per well) (for transfection control) using Lipofectamine 2000 Transfection Reagent (Invitrogen). The expression of hTLR9 and mCerulean was determined with primary rabbit anti-hemagglutinin (HA) Abs diluted 1:1000 (H6908; Sigma-Aldrich); rabbit anti-GFP diluted 1:1000 (A11122; Invitrogen); and secondary Abs goat anti-rabbit IgG-HRP diluted 1:4000 (ab6721; Abcam).
HEK293T cells seeded onto eight-well tissue culture chambers (Ibidi) at 2.2 3 10 5 cells per well were transfected with the plasmids expressing hTLR9 HA (140 ng DNA per well) and an EEA1-mTomato (80 ng). Localization was visualized 48 h post transfection. The hTLR9 HA was stained using rabbit anti-HA (H6908, 1:50; Sigma-Aldrich) and secondary Abs Alexa Fluor 647 F(ab9) 2 fragment of goat anti-rabbit IgG (H + L) (A21246, 10 mg/ml; Invitrogen). Successive images excited at 543 nm (fluorescence emission, 560-620 nm) and 633 nm (fluorescence emission, 650-700 nm) were captured using the Leica TCS SP5 inverted laser-scanning microscope on a Leica DMI 6000 CS module equipped with an HCX PlaneApochromat l blue 63 3 oil-immersion objective with NA 1.4 (Leica Microsystems). Images were processed with LAS AF software (Leica Microsystems) and ImageJ software (National Institute of Mental Health, Bethesda, MD).
AlphaScreen TLR9 binding assay
The binding assays were performed in a final reaction volume of 25 ml assay buffer, which contained 50 mM MOPS-NaOH (pH 6.5), 100 mM NaCl, 0.01% (w/v) Tween 20, and 1 g/l BSA in a half 96-well plate (PerkinElmer). The ODNs labeled with biotin-TEG at 39 (Integrated DNA Technologies) were used. In the assay, 5 ml cell lysate (prepared as described below) was incubated with an ODN (#75 mM final concentration) for 1 h at 23˚C. Anti-HA acceptor beads (20 mg/ml final concentration) were added and incubated for 1 h at 30˚C. Then, streptavidin-coated donor beads (20 mg/ml final concentration) were added and incubated for 30 min at 30˚C before the signals were measured with EnVision (PerkinElmer). The binding of ODN to wt-hTLR9 HA or wt-hTLR9 ectodomain (ECD) -Fc after subtraction of intrinsic activity (no ODN) are shown as AlphaScreen units (all n = 3, 6 SD; two independent experiments).
HEK293T cells were transiently transfected with plasmid expressing hTLR9 HA (735 mg DNA per well) using Lipofectamine Transfection Reagent (Invitrogen). After 48 h, cells were lysed in 0.2 ml lysis buffer [50 mM Tris-HCl (pH 7.4), 1 mM EDTA, 150 mM NaCl, 0.5% Triton X-100, 20% glycerol, 1 mM Na 3 VO 4 , 25 mM NaF, and 1 mM PMSF] containing a cOmplete Mini Protease Inhibitor (Roche) for 10 min on ice. Then, cell lysates were centrifuged (10.000 rpm, 10 min, 4˚C).
Internalization of ODNs
The Ramos-Blue cells at 1 3 10 6 cells per well were treated with ODNs conjugated at 39 with fluorescent dye (1 mM final concentration): minM-75 ATTO647 and ODN2006 ATTO488 or polyT ATTO488 . As negative control, untreated cells were used. At 5 h after treatment, the cells were washed, and internalization of ODNs was analyzed using flow cytometry and cells were imaged with confocal microscopy. Successive images excited at 488 nm (fluorescence emission, 500-570 nm) and 633 nm (fluorescence emission, 650-700 nm) were captured.
Fluorescence spectroscopy
The dsDNA in solution was analyzed using the Quant-iT dsDNA HighSensitivity Assay Kit (Molecular Probes, Invitrogen). A PicoGreen dye, when bound to dsDNA, fluoresced at 523 nm when excited with 502-nm light. The formation of dsDNA was determined with PicoGreen dye at 37˚C (or at 22˚C) with the Synergy Mx (BioTek) spectrofluorimeter according to the manufacturer's guidelines.
Cytokine detection
Human PBMCs were extracted from whole blood using density gradient medium Lymphoprep and SepMate tubes (STEMCELL Technologies). PBMCs were cultured in 96-well round-bottom plates (0.2 ml per well; 0.5-1 3 10 6 cells per well) and stimulated with ODNs. Culture supernatants were collected after 16 h. The secreted human TNF-a and IFN-g were determined with ELISA (human TNF-a and human IFN-g Ready-SET-Go ELISA; eBioscience).
Untouched B cells were isolated from PBMCs by negative selection with CD43 beads (Miltenyi Biotec). B cells were cultured in 96-well roundbottom plates (0.5-1 3 10 5 cells in 0.1 ml per well) and stimulated with ODNs. Cells were treated with human FcR blocking reagent and stained with anti-hCD19-FITC, anti-hCD20-VioBlue and anti-hCD69-PE according to the manufacturer's instructions (Miltenyi Biotec).
Software and statistics
Program IDT OligoAnalyzer 3.1 (www.idtdna.com/analyzer/applications/ oligoanalyzer/) using the program settings, assuming a temperature of 37˚C, 150 mM Na + , and 0.5 nM Mg 2+ , was used to calculate the Gibbs free energy of the ODN homodimer. Graphs were prepared with Origin 8.1 (www.originlab.com/), and GraphPad Prism 5 (www.graphpad.com/) was used for statistics. The Student unpaired two-tailed t test was used for statistical comparison of the data.
Results
CpG motif at the 59 end of the ODN is essential for TLR9 activation
The number and position of the CpG motifs of ODN2006 PD and ODN2395
PD were varied to determine the minimal sequence necessary for activating the immune response of B cells and hTLR9-transfected HEK293 cells. B-class ODN2006
PD and, to a lesser degree ODN2395 PD (C-class), activated NF-kB/AP-1 of the Ramos-Blue cells (Fig. 1) . The well-established B-type agonist ODN2006 consists of three CpG-comprising motifs: a 59 located TCGTCGT motif with two CG dinucleotides, followed by the middle GTCGT sequence, and a GTCGT sequence at the 39 end. We substituted one or more CG sequences with TT, and TLR9 activation (NF-kB/AP-1) of the Ramos-Blue cells was measured after the cells were treated with ODN2006 PD and its variants ( We also examined the impact of the CpG motif (59-TCGTCGT) at the 59 end of the C-type ODN2395 PD on hTLR9 activation. Substitution of the first CG with TT or GC led to a strong decrease in TLR9 activation (Fig. 1C, ODN-C2 , -C7 compared with ODN2395 PD ), whereas the second CG dinucleotide was much less important (ODN-C3, -C8 compared with ODN2395 PD ). However, no TLR9 activation was observed when both 59-CGs were substituted with TT (ODN-C9).
We examined the effect of the increased number of CG motifs by designing longer ODNs: 32-nt-long ODNs CG 1 -l 32 -F and CG 6 -l 32 -F, and 40-nt-long CG 8 -l 40 -F with 1, 6, and 8 CG dinucleotides, respectively. The activity of CG 1 -l 32 -F with only a single CpG was still 50% of the activity of ODN2006
PD . The CG 6 -l 32 -F and CG 8 -l 40 -F with six and eight CGs activated TLR9 of the Ramos-Blue cells better than the reference ODN2006 PD (Supplemental Fig. 2A ).
When the guanosines within the GG, GC, and CG dinucleotides, except the 59-CG, were substituted with C, the efficacy in activating NF-kB signaling decreased significantly (Supplemental Fig. 2A ; CG 1 -l 32 -cont, CG 6 -l 32 -cont, and CG 8 -l 40 -cont). The results confirmed the crucial role of the 59-CG and the requirement of at least another CpG within the ODN PD to activate B cells and hTLR9-expressing HEK293 cells.
The adenosine adjacent to the CG dinucleotide reduces the efficacy of ODNs For human cells, the species-specific motif that activates TLR9 was proposed to be GTCGTT (12), whereas GACGTT was proposed for mice (1) , (24) . Therefore, we analyzed the consequences of replacing thymidine with the adenosine adjacent to the CG in the CpG motifs on TLR9 activation. These substitutions decreased TLR9 activation. In particular, the adenosine adjacent to the first CG dinucleotide decreased NF-kB/AP-1 activity by .70% (Fig. 2, ODN-23, -11, -25 ). Several adenosines are present within the sequence of long ODNs; however, the adenosines that are remote from the CpG motifs in CG 6 -l 32 -woA and CG 8 -l 40 -woA had almost no influence on the stimulation (Supplemental Fig. 2B ). Nonetheless, substitution of five adenosines within the CG 1 -l 32 -woA improved TLR9 activation. This finding suggests that the A adjacent to 59-CG had a strong negative effect on activation of the hTLR9, whereas the adenosines placed elsewhere had only a minor impact.
Separation of the CpG motifs modulates TLR9 activation
Initial analysis of the CpG motifs required for TLR9 activation suggested that the distance between the CpG motifs is not a particularly critical parameter (Fig. 1A, ODN-13 , -57). To elaborate the requirements for the distance between the 59, middle, and 39 CpG motif in more detail, we designed ODN2006 PD variants with two to nine thymidines between the CpG motifs. As a consequence of the thymidine insertions, the lengths of the ODNs varied from 20 to 34 nt (Fig. 3A) . The ODN-5 with only two thymidines between the CpG motifs (20 nt long) preserved 60% TLR9 activity. Insertion of three to eight thymidines between CpG motifs (ODN-7, -8, -6) preserved or even slightly increased the ability of the agonist to activate TLR9 (Fig. 3A) . Similarly, an insertion of seven or nine thymidines between the 59 CpG motif and the CG-rich palindrome of ODN2395 PD improved the TLR9 activation compared with that of ODN2395 PD (Fig. 3B ). Initial screening (Fig. 3C) suggested that only two CpG motifs within the ODN are sufficient to activate B cells. Therefore, we analyzed the minimal number of CG dinucleotides and their po-sition within the ODN that promote TLR9 activation comparable to that of ODN2006 PD . Substitution of the second CG within the 59 CpG motif (59-TCGTCGT) of ODN2006 with TT, accompanied by the replacement of the 39 CpG (GTCG) with TTTT, was well tolerated, with only a minor decrease in TLR9 activation (Fig. 3D, ODN-53, -54 ). To summarize, only two CG dinucleotides within the ODN were required for receptor activation. We also determined that the 59-CG dinucleotide and the CpG motif separated by four to eight thymidines were well tolerated.
Dimer formation decreases NF-kB/AP-1 activation
The ssDNA is a ligand for TLR9 (1); however, intra-and intermolecular secondary-structure-forming ODNs stimulate type I IFN secretion (12-16, 19, 27) . ODN2395 forms a homodimer mediated by the 39-CG-rich palindromic sequence. For the ODN2395 dimer, the predicted DG was 236.75 kcal/mol. Formation of the dsDNA was monitored using PicoGreen, a dsDNAspecific dye. Variants of ODN2395 PD were prepared with modifications in the palindromic segment of ODN2395, rendering the duplex less stable (Fig. 4A, ODN-C4 , -C6, -C10, -C5; Supplemental Fig. 2C , TLR9-expressing HEK293 cells). As expected, gradual replacement of the palindromic sequence with thymidines decreased the intensity of fluorescence, which indicates the disrupted stability of the dimer (Fig. 4B, 4D ). We observed a negative correlation between the stability of the dimer formation and hTLR9 activation at 37˚C and 22˚C (Pearson's correlation coefficient 20.88 and 20.65, respectively) ( Fig. 4C,  4D; Supplemental Fig. 2D ). This finding reflects the transition from C-type to B-type ODN, which is a more potent activator of B cells (Fig. 4A) .
To demonstrate that the decrease in activity is due to the formation of the duplex and the decreased content of single-stranded DNA rather than to a particular sequence, we used a mixture of long ODNs with their reverse complement sequences. Other TLR9 stimulatory ODNs reported in the literature that contain a duplex all formed homodimers. ODNs that form a heterodimeric duplex over the 39 segment of the ODN with the remaining single-stranded 59-TCGT motif showed a negative impact of ODN dimerization on TLR9 activation. Although each of the components (CG 1 -l 32 -F/R, CG 6 -l 32 -F/R, CG 8 -l 40 -F/R) stimulated TLR9, the mixture of each strongly impaired TLR9 activation (Supplemental Fig. 2E ) (15, 28) , with ,30% TLR9 activity compared with that of ODN2006 PD or the activity of individual monomers (Supplemental Fig. 2F ). This result reflects the transition from B-to C-type ODN, demonstrating the preference for single-stranded conformation over the entire length of the ODN.
The minimal sequence requirements of ODNs for TLR9 activation
On the basis of these results, we selected pairs of CG dinucleotides and systematically modified their position and distance within the ODN. An ODN comprising only two TCGT motifs had $80% of the activity of ODN2006 PD (Fig. 5A, ODN-46) . Shortening of the poly-T tail at the 39 end strongly decreased activity (Fig. 5B,  ODN-74, ODN-73) . Any other nucleotide except T adjacent to the 59-CG sequence considerably impaired the activation of TLR9 (Fig. 5E , ODN-86 U,-87 deoxyribose backbone, -83, -64, -82). In addition, shifting 59-CG farther toward the 39 end, but retaining the length of the ODN, led to a stepwise decrease in receptor activity (Fig. 5C) . Therefore, the 59-CG dinucleotide must be positioned next to the 59 thymidine. As seen in the ODN2006 PD variants (Fig. 1A, ODN-20; Fig. 1C, ODN-C9 ,-C2,-C7; Supplemental Fig. 2A , long ODNs), as well as for minH, at least two CG dinucleotides were required for TLR9 activation (Fig. 5D) . The length of minH and the distance between the CG dinucleotides fine-tune the ODN's activation potency ( Fig. 5F, 5G ; Supplemental Fig. 3A, 3B) . The CG dinucleotide motifs should be separated by 6-10 nt for the best activity (Fig. 5F ). This finding was also confirmed for minH ODNs that are 30 nt long (Fig. 5G) . We replaced the poly-T spacer between the CG motifs and the 39 poly-T tail with poly-C, G, or A sequences. These nucleotide substitutions considerably diminished the potency of minH to activate TLR9 (Fig. 5H) . Cytidines replacing the poly-T spacer or tail had a less detrimental effect than the larger purines A and G. Consequently, the poly-T tail at the 39 end should be between 9 and 19 nt long. As determined by AlphaScreen assay, the 24-nt-long ODNs with different numbers of CG dinucleotides (ODN2006, minH-75) bound TLR9 with similar affinity regardless of the sequence (Supplemental Fig. 4A ). The minH-30 with only the 59 TCG motif and the minH-64 with the ACG motif at the 59 end bound TLR9 with lower affinity. The 15-nt-long ODN (minH-70) and poly-T did not bind to TLR9. The internalization of ODNs (ODN2006 and minH-75 or poly-T) to B cells was not sequence dependent, and 5 h after ODN treatment, all RamosBlue cells contained both ODNs (Supplemental Fig. 4B, 4C ). To summarize, the minimal sequence of minH that activates TLR9 is TCG[T] 6-10 CG[T] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] , with the length of the ODN ranging from 21 to 30 nt.
Response of human PBMCs and B cells to the minimal ODN
Because internalization and nuclease digestion might play a role in TLR9 activation, we tested in parallel the activation of TLR9 by minH ODN with PD and PTO backbones (Fig. 6A) . The responses of the B cells triggered by minH ODN and ODN2006 were comparable. It was found that 5-10 times less ODN with the PTO backbone was needed for the full activation of TLR9 than was needed for ODNs with the PD backbone (Fig. 6A) , suggesting that the recognition site is optimized for PDs.
Substitution of the PTO backbone with the PD backbone for only the 59-CG dinucleotide in the P-class ODN triggers stronger TLR9 signaling (17) . Therefore, we examined whether the type of backbone determines the efficiency of TLR9 activation. The minH ODNs with mixed PD-PTO backbone content were tested on B cells. The minH with the PD-linked 59-TCGT tetranucleotides, with the rest of the nucleotides linked by PTO (minH-75 PTO -CG 1 PD ), was the most efficient activator of B cells (Fig. 6B) .
Finally, we analyzed minH ODN efficiency to promote a cytokine response in human PBMCs and B cells (CD43-negative) (Supplemental Fig. 4D , CD19-and CD20-positive cells). Min-H PTO was as efficient as ODN2006 PTO in stimulating TNF-a, IFN-g, and IL-6 release from PBMCs. The minH PD also triggered the secretion of TNF-a at a 4-fold higher concentration compared with the PTO ODNs (Fig. 6C) . IFN-a was determined in the presence of the ODN2006 and minH with PD backbone 16 h after the PBMCs were stimulated. ODN2006
PTO and minH-75 PTO triggered the expression of the cell surface marker CD69 on B cells (Fig. 6D) . In summary, the minimal sequence requirement for ODNs to stimulate human TLR9 is two CpG motifs, separated preferably with the oligo-T spacer and the oligo-T tail at the 39 end (Fig. 6E) . For efficient activation, the CG motifs should be separated by between 4 and 10 nt, and the ODN should be longer than 21 nt. The sequence requirement for the 59-TCGT motif is very stringent because the substitution of the T next to CG with any other nucleotide strongly reduced the ability to activate TLR9. The requirements for the second CG motif and nucleotides adjacent to the CG dinucleotide are less rigorous, and substitutions of the nucleotides next to CG only mildly affect the efficiency of activating human TLR9. These facts suggest two probable binding sites within the TLR9 dimer with different binding affinities for the CG dinucleotide: one that binds the 59-TCG motif and one that should bind less stringently.
Discussion
Synthetic CpG ODNs are potent stimulators of immune cells expressing TLR9; however, different classes of ODNs that differ in terms of their sequence elicit diverse cytokine patterns (1, 11, 15, 16) . In this study, we identified the minimal sequence motifs of Bclass ODNs that effectively activate B cells, PBMCs, and HEK293 cells transfected with human TLR9. We identified minH by the sequence pattern TCG[T] 6-10 CG[T] 9-19 that contains two CG sequences separated with a 6-to 10-nt-long thymidine spacer. The first CpG motif starts at the 59 end of ODN, and at the 39 end, a poly-T tail is required. The minH ODN should be longer than 21 nt for the efficient activation of TLR9, which might be due to either increased protection against exonucleases or sequenceindependent binding to the receptor. The minH PD ODN activates NF-kB/AP-1 signaling in B cells as efficiently as ODN2006 PD . Although we cannot exclude the possibility that the length requirement and the addition of the 39 oligo-dT tail may be due to stability against the exonuclease, the similar activation of the PTO-based activation by minH and ODN2006 suggests that this is not the case.
The 59-CG seems to be most important, but not sufficient, for TLR9 activation, as previously determined in the design of the generally used ODN2006 PTO and ODN2395 PTO (12, 23, (29) (30) (31) . The backbone modification to 29-O-methyl ribose within the 59 CpG motif, but not within the 39-CG-rich sequence, of the C-class ODN led to the complete loss of IFN-a secretion (30) , confirming the importance of 59-CG and deoxyribose in the activation of TLR9. Moreover, CpG ODNs containing a 39 hairpin structure, but not the 59, are immunostimulatory (20) , which is consistent with the finding that the accessible 59 CpG motif is necessary for activating TLR9. The binding of ODNs to TLR9 showed weak sequence dependence, and shorter minH ODN and ODN with 59-ACG motif poorly bound TLR9. Latz et al. (32) , Ashema et al. (33) , and Kindrachuk et al. (34) identified that ODNs bind mTLR9 in a sequence-independent manner. However, Rutz et al. (35) demonstrated the sequencedependent binding of ODN to mTLR9. The number of CG dinucleotides within the ODN is another parameter that defines the agonist's efficacy in activating TLR9 of B cells as well as PBMCs. More than two CpG motifs improve TLR9 activation, which is understood not only for ODN2006 PD and ODN2006 PTO (23, 29) but also for long ODNs. The CD32 and CD40 with six and eight CG sequences activate B cells better than ODN2006
PD (per mole, but not per mass), although three or more CG dinucleotides within a 22-to 25-nt-long ODN does not enhance activity any further (2).
Nucleotides adjacent to the CG dinucleotide are also important for agonist potency and are an integral part of the CpG motif (12), probably reflecting the binding specificity of the site on the TLR9 ECD. Substitution of the thymidine adjacent to the 59-CG with any other nucleotide strongly reduced the ability to activate human TLR9. In contrast, the T to A substitution next to any other CG had only a moderate negative effect on activation. Moreover, the poly-T tail at the 39 end of the minH ODN, which defines the length requirement of the ODN, is necessary for efficient activation. The distance between two essential TCGT motifs fine-tunes TLR9 activation. We showed that TCGT sequences four to eight thymidines apart in minH and ODN2006 PD led to the highest TLR9 activity, as shortening or extending the thymidine spacer outside this range decreases the ODN's efficacy to activate TLR9.
The sequence difference in the A-, B-, C-, and P-classes predominantly defines the secondary structure of ODNs, which, according to the literature, is the main reason for differences in the activation of B cells and pDCs as well as the secretion of different cytokines (36-39) . The synthesis of type I IFNs is primarily linked to the A-class ODNs (12-14) , most likely owing to the different cellular internalization pathway. The latter was also associated with the route of endocytosis and the location of ODNs in differently matured endosomes (14, 40) . Nanoparticles loaded with B-class CpG ODNs that mimic A-and P-class ODN aggregates are as effective as A-class ODNs at inducing IFN-a in pDCs and PBMCs (36, 41) . This finding implies that the propensity of ODNs to internalize into early endosomes, rather than the specific DNA binding motif, drives MyD88/IRF7-dependent signaling and IFN-a synthesis (40) . The B-class ODNs, like minH-75, internalized sequence independently; however, the route of internalization is probably not linked to IRF7-dependent activation, which would trigger type I IFNs. The C-class ODN, in addition to the 59 CpG motif identical to ODN2006, contains a 39-CG-rich palindrome that participates in forming homodimers (16) . The substitutions within the CG-rich palindromic sequence that preserves the palindrome were well tolerated. We demonstrated that it is possible to design an apparently smooth transition from C-to B-type ODNs by modulating the stability of the palindromic segment. Although many ODNs have been investigated, few systematic studies have been conducted to unravel the key sequence determinants that govern activation of TLR9 by ODNs. The substitutions that destroy the palindrome, however, decrease IFN-a secretion and increase the secretion of IL-6 cells in B cells (16) . Negative correlation between dimer formation and NF-kB/AP-1 activation was also confirmed with long ODNs and C274 ODN (28) . Weaker activation by C-type-like ODNs compared with B-type-like ODNs can be explained by binding to only one CpG binding site, leaving the other CpG binding site unoccupied, which leads to less effective activation of TLR9.
There are differences in the TLR9 activation between ODNs based on the PD and PTO backbones. Introduction of the nucleaseresistant PTO backbone improved the ODN's uptake and hindered degradation by nucleases. A disadvantage of PTO modifications is the induction of an immune response independent of the CpG motif (42) (43) (44) , which obscures the motif of the physiologically relevant agonists. The PTO-based minH ODN chimera comprising PD-based 59-TCGT maintained the ODN's species-specific specificity while retaining protection of the ODN against nucleases. Therefore, such chimeric ODNs are as efficient stimulators of immune cells as ODNs with the PTO backbone.
The minimal sequence motif of ODN required for TLR9 activation contributes to elucidation of the recognition specificity of the ligand-TLR9 interactions. Requirements for the minimal ODN motif suggest that at least two nonequivalent sites at the hTLR9 ECD dimer must be present to interact with CG dinucleotides. One CG recognition site of TLR9 must recognize the 59-CG motif and specifically distinguish thymidine as the first nucleotide. The other CpG binding site, where the recognition of CG bases is probably less stringent, is located apart from the first CG recognition site. The best activation of TLR9 is achieved with ODNs with CG dinucleotide motifs separated with a spacer of at least six nucleotides, which corresponds to a distance of ∼40-50 Å and is probably the distance between the binding sites on the TLR9 ECD dimer. In addition, the poly-T tail at the 39 end of ODN that is $10 nt long probably serves as an initial nonspecific binding of ssDNA to TLR9 through a negative phosphate backbone and a positive interface on TLR9. Those structural requirements will also support the design of improved activation because we demonstrated that some ODNs, particularly those that are longer, cause stronger activation than ODN2006. 
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